biotech innovation

New vaccines employing biotech innovations are changing the way we prevent illness.  Dr. Targan explains how biotech researchers are discovering new ways to prevent illnesses such as HPV, hepatitis-B, meningitis, and even the flu through new and improved research, manufacturing, and delivery mechanisms.

Download to listen or view the podcast.

BIOtech Now’s Tracy Krughoff talks to Dr. David Agus of the University of Southern California’s Westside Prostate Cancer Center and the Center for Applied Molecular Medicine. His research focuses on the application of proteomics and genomics for the study of cancer and the development of new therapeutics for prostate cancer. Dr. Agus also is one of the judges for the Biotechnology Humanitarian Award, which will be given at the 2010 BIO International Convention.

Listen to the podcast:
http://www.bio.org/podcasts/agus.wma

BIOtech Now’s Tracy Krughoff talks to Dr. Kim Hunter-Schaedle, Chief Scientific Officer of the Children’s Tumor Foundation, which is dedicated to ending neurofibromatosis through research.

We issued a late breaking call for sessions for the 2010 BIO International Convention today. Open for 4 Days  - Due Thursday, February 4th http://tinyurl.com/yej8j8c To respond to requests for recent and timely session topics, we are accepting six new late-breaking sessions for the 2010 BIO International Convention.

Patient advocacy groups have many different roles.  They are educators, they provide a support system for individuals and families of people living with illness, they lobby for increased research, and are increasingly providing funding to biotech companies to encourage further research and development of promising, and potentially life-saving therapies.  At the 2009 BIO International Convention, we met with patients  and patient advocates to learn more about how advocacy groups are working together with biotech researchers to promote innovative research and creation of therapies that may one d

Biosimilars, also known as follow-on biologics, may eventually expand access and provide patients a more affordable alternative to innovative, lifesaving medicines. However, there are a few important safeguards that must be put into place before these “similar but not the same” versions of biologics can be safely introduced to the public.  Join Dr.

What do pandas, bantengs, and panthers have in common?  Their populations have all been assisted by biotechnology.  Whether endangered, or unhealthy due to a lack of biodiversity, advances in biotechnology - including animal cloning and assisted reproductive technologies, have helped these animals, and many others, to increase their populations, become healthier, and enjoy a more genetically diverse environment.

Download to listen or view the podcast.